SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

NovaBay Pharmaceuticals, Inc. 
 CA
  SEC # 1389545


        
    Click to view...      Registrant      About      Filings      Files      Relationships      Names    
  Topics  
    Web       

107  Topics
Topic emoji
 within the 

Show:   Most-Recent Document   All Documents   And:   Exhibits  

 As Of  Filing  Doc.  Page    Title Docs.
  In ascending order
3/26/2410-K1Business
1Certain Relationships and Related Transactions, and Director Independence
1Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
8/10/2310-Q1Condensed Consolidated Balance Sheets: June 30, 2023 (unaudited) and December 31, 2022
5/11/2310-Q1Condensed Consolidated Balance Sheets: March 31, 2023 (unaudited) and December 31, 2022
5/9/24New Filing!  10-Q1Condensed Consolidated Balance Sheets: March 31, 2024 (unaudited) and December 31, 2023
11/9/2310-Q1Condensed Consolidated Balance Sheets: September 30, 2023 (unaudited) and December 31, 2022
1Condensed Consolidated Statements of Cash Flows: Nine months ended September 30, 2023 and 2022 (unaudited)
8/10/2310-Q1Condensed Consolidated Statements of Cash Flows: Six months ended June 30, 2023 and 2022 (unaudited)
5/11/2310-Q1Condensed Consolidated Statements of Cash Flows: Three months ended March 31, 2023 and 2022 (unaudited)
5/9/24New Filing!  10-Q1Condensed Consolidated Statements of Cash Flows: Three months ended March 31, 2024 and 2023 (unaudited)
11/9/2310-Q1Condensed Consolidated Statements of Operations: Three and nine months ended September 30, 2023 and 2022 (unaudited)
8/10/2310-Q1Condensed Consolidated Statements of Operations: Three and six months ended June 30, 2023 and 2022 (unaudited)
5/11/2310-Q1Condensed Consolidated Statements of Operations: Three months ended March 31, 2023 and 2022 (unaudited)
5/9/24New Filing!  10-Q1Condensed Consolidated Statements of Operations: Three months ended March 31, 2024 and 2023 (unaudited)
11/9/2310-Q1Condensed Consolidated Statements of Stockholders ' Equity: Three and nine months ended September 30, 2023 and 2022 (unaudited)
5/9/24New Filing!  10-Q1Condensed Consolidated Statements of Stockholders ' Equity: Three months ended March 31, 2024 and 2023 (unaudited)
8/10/2310-Q1Condensed Consolidated Statements of Stockholders' Equity: Three and six months ended June 30, 2023 and 2022 (unaudited)
5/11/2310-Q1Condensed Consolidated Statements of Stockholders' Equity: Three months ended March 31, 2023 and 2022 (unaudited)
3/26/2410-K1Consolidated Balance Sheets as of December 31, 2023 and 2022
1Consolidated Statements of Cash Flows for the Years Ended December 31, 2023 and 2022
1Consolidated Statements of Operations for the Years Ended December 31, 2023 and 2022
1Consolidated Statements of Stockholders ' Equity for the Years Ended December 31, 2023 and 2022
5/9/24New Filing!  10-Q1Controls and Procedures
3/26/2410-K1Cybersecurity
5/9/24New Filing!  10-Q1Defaults Upon Senior Securities
3/26/2410-K1Directors, Executive Officers and Corporate Governance
1Disclosure Regarding Foreign Jurisdictions That Prevent Inspections
1Executive Compensation
8/10/2310-Q1Exhibit Index
5/9/24New Filing!  10-Q1Exhibits
3/26/2410-K1Exhibits and Financial Statement Schedules
5/9/24New Filing!  10-Q1Financial Statements
3/26/2410-K1Financial Statements and Supplementary Data
5/9/24New Filing!  10-Q1Legal Proceedings
1Management ' s Discussion and Analysis of Financial Condition and Results of Operations
3/26/2410-K1Management's Discussion and Analysis of Financial Condition and Results of Operations
1Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
5/9/24New Filing!  10-Q1Mine Safety Disclosures
1Notes to Condensed Consolidated Financial Statements (unaudited)
3/26/2410-K1Notes to Consolidated Financial Statements
5/9/24New Filing!  10-Q1Other Information
3/26/2410-K1Part I
1Part Ii
1Part Iii
1Part Iv
5/17/23S-1/A1Power of Attorney (included on the signature page to this registration statement)
3/26/2410-K1Principal Accountant Fees and Services
1Properties
5/9/24New Filing!  10-Q1Quantitative and Qualitative Disclosures About Market Risk
3/26/2410-K1Report of Independent Registered Public Accounting Firm
1Reserved
5/9/24New Filing!  10-Q1Risk Factors
3/26/2410-K1Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
5/9/24New Filing!  10-Q1Signatures
3/26/2410-K1Table of Contents
5/9/24New Filing!  10-Q1Unregistered Sales of Equity Securities and Use of Proceeds
11/9/2310-Q1Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities
3/26/2410-K1Unresolved Staff Comments

Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 3:58:20.2pm ET